SCHEMBL6990105

SCHEMBL6990105

COc1ccc(C(=CC=O)c2cc(-c3cc4ccccc4s3)ccc2OC)cc1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNFRSF1A P19438 8/20 0.60
ERN1 O75460 2/20 0.49
S1PR1 P21453 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
APP P05067 2/20 0.40
KDM4E B2RXH2 2/20 0.39
HTT P42858 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PIN1 Q13526 1/20 0.39
MAPT P10636 1/20 0.39
PPARG P37231 1/20 0.39
RAB9A P51151 1/20 0.39
NR2E3 Q9Y5X4 1/20 0.39
NCOR2 Q9Y618 1/20 0.39
ACLY P53396 1/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6991036 0.82 TNFRSF1A (0.64) TNFRSF1AERN1S1PR1HDAC6APP
SCHEMBL10436312 0.78 TNFRSF1A (0.61) TNFRSF1AERN1S1PR1APPKDM4E
SCHEMBL6989732 0.76 TNFRSF1A (0.61) TNFRSF1AERN1KDM4EHTTMAPT
SCHEMBL5574957 0.75 TNFRSF1A (1.00) TNFRSF1A
SCHEMBL5574955 0.75 TNFRSF1A (1.00) TNFRSF1A
SCHEMBL6091816 0.75 TNFRSF1A (0.55) TNFRSF1AERN1S1PR1HDAC6APP
SCHEMBL6990108 0.74 TNFRSF1A (0.60) TNFRSF1AERN1KDM4EL3MBTL1RAB9A
SCHEMBL6091543 0.74 ERN1 (0.71) TNFRSF1AERN1S1PR1APPMAPT
SCHEMBL9519816 0.72 CYP1A2 (0.58)
SCHEMBL6988580 0.70 TNFRSF1A (0.59) TNFRSF1AERN1TUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1330448-A2 1,3-BIS-(SUBSTITUTED-PHENYL)-2-PROPEN-1-ONES AND THEIR USE TO TREAT VCAM-1 MEDIATED DISORDERS Atherogenics, Inc. (US) 2003-07-30 EP claimed
WO-2001098291-A2 1,3-BIS-(SUBSTITUTED-PHENYL)-2-PROPEN-1-ONES AND THEIR USE TO TREAT VCAM-1 MEDIATED DISORDERS ATHEROGENICS, INC. (US) 2001-12-27 WO claimed